PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Nov-2023 NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support NorthX Biologics AB
01-Nov-2023 Anaveon announces presentation of ANV600 preclinical data supporting combination therapy with therapeutic PD-1 inhibitors Anaveon
01-Nov-2023 ViroCell and Great Ormond Street Hospital poised to unlock clinical trial ‘backlog’ following MHRA manufacturing approval ViroCell Biologics
01-Nov-2023 Aragen setting up a $ 30 million bio-manufacturing site in India Aragen
01-Nov-2023 Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap Businesswire
01-Nov-2023 Antibe Completes First Clinical Study of Otenaproxesul’s New Formulation Businesswire
01-Nov-2023 Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment Businesswire
01-Nov-2023 Can-Fite Issues Business Update: All Clinical Programs and Business Development Activities Remain Solidly on Track Businesswire
01-Nov-2023 IQVIA Reports Third-Quarter 2023 Results Businesswire
01-Nov-2023 Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease Businesswire
01-Nov-2023 Bioluminescence Ventures Emerges from Stealth with $477M AUM Businesswire
01-Nov-2023 Merck to Participate in the UBS BioPharma Conference Businesswire
01-Nov-2023 FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer Businesswire
01-Nov-2023 KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Nephrectomy Businesswire
01-Nov-2023 Biosimulation Market To Generate $10.6 Billion by 2032, Expeditious Annual Growth Predicted The Wire Times
01-Nov-2023 CBD Pouches Market Revenue to Touch $721.8 Million by 2032 | Big Corps Trends and Strategy Analysis  The Wire Times
01-Nov-2023 Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine Businesswire
01-Nov-2023 Prime Global Becomes Prime Prime
01-Nov-2023 CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK CureVac
01-Nov-2023 AGC Biologics Milan Receives Special Award Mention by Confindustria for Research and Innovation Businesswire